血糖变异系数和SNAPPE-II与危重新生儿预后的相关性

doi:10.12372/jcp.2023.22e0086

Abstract

Abstract:

Objective To explore the association of coefficient of glycemic variation (CV) and score for neonatal acute physiology with perinatal extension-Ⅱ (SNAPPE-Ⅱ) with prognosis in critically ill neonates. Methods The clinical data of critically ill neonates admitted to the neonatal intensive care unit (NICU) from August 2018 to September 2020 were retrospectively analyzed. According to the prognosis, they were divided into death group and survival group, and the difference of clinical features between the two groups was compared. Binary logistic regression model was used to analyze the risk factors of poor prognosis in critically ill neonates. Receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic value of CV and SNAPPE-Ⅱ in poor prognosis of critically ill neonates. Results A total of 385 critically ill newborns were included, including 228 boys and 157 girls. The median age of admission was 1.0 (1.0-24.0) hours, the mean gestational age was (35.3±4.1) weeks, and the mean weight was (2456.6±860.3) grams. There were 85 hypoglycemic and 115 hyperglycemic patients. There were 80 patients in the death group, and the median time from NICU admission to death were 5.0 (2.0-10.3) days. Binary logistic regression analysis showed that CV, SNAPPE-Ⅱ, gestational age, weight, the main diagnosis of pulmonary hemorrhage and neonatal sepsis were correlated with death of critically ill neonates (P<0.05). The area under curve (AUC) of CV predicting death of critically ill neonates was 0.72, and the AUC of SNAPPE-Ⅱwas 0.85. When CV≥0.31, the sensitivity and specificity for the diagnosis of critical neonatal death were 0.75 and 0.59. When SNAPPE-Ⅱ≥18.50, the sensitivity and specificity for the diagnosis of critical neonatal death were 0.68 and 0.93. Conclusions Both CV and SNAPPE-Ⅱ have certain predictive values for the poor prognosis of critically ill neonates.

Key words: critically ill neonate, coefficient of glycemic variation, score for neonatal acute physiology with perinatal extension-Ⅱ, prognosis

XIANG Chao, ZHANG Rong, KANG Lan, LEI Xiaoping, LIU Xingqing, DONG Wenbin. Association of coefficient of glycemic variation and SNAPPE-Ⅱ with prognosis in critically ill neonates[J].Journal of Clinical Pediatrics, 2023, 41(6): 430-435.

Figures/Tables 4

References 31.

[1]	邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 5版. 北京: 人民卫生出版社, 2019:291-917.
[2]	Brekke E, Morken TS, Sonnewald U. Glucose metabolism and astrocyte-neuron interactions in the neonatal brain[J]. Neurochem Int, 2015, 82: 33-41. doi: 10.1016/j.neuint.2015.02.002 pmid: 25684072
[3]	Boardman JP, Wusthoff CJ, Cowan FM, et al. Hypoglycaemia and neonatal brain injury[J]. Arch Dis Child Educ Pract Ed, 2013, 98(1): 2-6. doi: 10.1136/archdischild-2012-302569 pmid: 23086597
[4]	Gu MH, Amanda F, Yuan TM. Brain Injury in Neonatal Hypoglycemia: a Hospital-Based Cohort Study[J]. Clin Med Insights Pediatr, 2019, 13: 1179556519867953.
[5]	Adeniji EO, Kuti BP, E Elusiyan JB. Prevalence, risk factors, and outcome of hospitalization of neonatal hyperglycemia at a Nigerian health facility[J]. Niger J Clin Pract, 2020, 23(1): 71-78. doi: 10.4103/njcp.njcp_229_19 pmid: 31929210
[6]	韦欢, 张忠垚, 李禄全. 影响新生儿毛细血管渗漏综合征预后的危险因素[J]. 临床儿科杂志, 2020, 38(4): 246-249.
[7]	Alexandrou G, Skiöld B, Karlén J, et al. Early hyper-glycemia is a risk factor for death and white matter reduction in preterm infants[J]. Pediatrics, 2010, 125(3): e584-e591. doi: 10.1542/peds.2009-0449
[8]	Candido R. Which patients should be evaluated for blood glucose variability?[J]. Diabetes Obes Metab, 201, (Suppl 2): 9-12.
[9]	Kulkarni H, Bihari S, Prakash S, et al. Independent association of glucose variability with hospital mortality in adult intensive care patients: results from the Australia and New Zealand intensive care society centre for outcome and resource evaluation binational registry[J]. Crit Care Explor, 2019, 1(8): e0025. doi: 10.1097/CCE.0000000000000025
[10]	娄然, 姜利. 血糖变异度与重症患者预后不良的相关性[J]. 中华医学杂志, 2015, 95(7): 523-526.
[11]	Naranje KM, Poddar B, Bhriguvanshi A, et al. Blood glucose variability and outcomes in critically ill children[J]. Indian J Crit Care Med, 2017, 21(3): 122-126. doi: 10.4103/ijccm.IJCCM_364_16
[12]	王春林, 卢惠飞. 新生儿糖尿病的诊治思路[J]. 临床儿科杂志, 2022, 40(5): 328-333.
[13]	张德双, 谢东可, 何娜, 等. 新生儿不同浓度红细胞换血治疗疗效及对内环境的影响[J]. 临床儿科杂志, 2019, 37(12): 940-945.
[14]	谢幸, 孔北华, 段涛. 妇产科学[M]. 9版. 北京: 人民卫生出版社, 2018: 107-155.
[15]	Abramowski A, Ward R, Hamdan AH. Neonatal Hypoglycemia[M]. Treasure Island (FL): StatPearls Publishing, 2023.
[16]	杜语慧, 李静, 刘成军. 不同年龄危重患儿血糖波动与预后关系的研究[J]. 中国实用儿科杂志, 2020, 35(6): 471-477.
[17]	Atamna A, Ayada G, Akirov A, et al. High blood glucose variability is associated with bacteremia and mortality in patients hospitalized with acute infection[J]. QJM, 2019, 112(2): 101-106. doi: 10.1093/qjmed/hcy235 pmid: 30325467
[18]	Okazaki T, Hifumi T, Kawakita K, et al. Blood glucose variability: a strong independent predictor of neurological outcomes in aneurysmal subarachnoid hemorrhage[J]. J Intensive Care Med, 2018, 33(3): 189-195. doi: 10.1177/0885066616669328 pmid: 27630011
[19]	Fendler W, Walenciak J, Mlynarski W, et al. Higher glycemic variability in very low birth weight newborns is associated with greater early neonatal mortality[J]. J Matern Fetal Neonatal Med, 2012, 25(7): 1122-1126. doi: 10.3109/14767058.2011.624220 pmid: 21923328
[20]	Ahmad S, Khalid R. Blood glucose levels in neonatal sepsis and probable sepsis and its association with mortality[J]. J Coll Physicians Surg Pak, 2012, 22(1): 15-18.
[21]	孙才智, 仲伯蒙, 沈华, 等. 6 h内血糖变异度对脓毒性休克患者短期预后的预测价值[J]. 中华危重病急救医学, 2021, 33(1): 28-32.
[22]	Lv Y, Zhu LL, Shu GH. Relationship between Blood glucose fluctuation and brain damage in the Hypoglycemia Neonates[J]. Am J Perinatol, 2018, 35(10): 946-950. doi: 10.1055/s-0038-1626706
[23]	Pinchefsky EF, Hahn CD, Kamino D, et al. Hyperglycemia and glucose variability are associated with worse brain function and seizures in neonatal encephalopathy: a prospective cohort study[J]. J Pediatr, 2019, 209: 23-32. doi: 10.1016/j.jpeds.2019.02.027
[24]	Al Shafouri N, Narvey M, Srinivasan G, et al. High glucose variability is associated with poor neurodevelopmental outcomes in neonatal hypoxic ischemic encephalopathy[J]. J Neonatal Perinatal Med, 2015, 8(2): 119-124. doi: 10.3233/NPM-15814107 pmid: 26410435
[25]	Jagła M, Szymońska I, Starzec K, et al. Impact of early glycemic variability on mortality and neurologic outcome of very low birth weight infants: data from a continuous glucose monitoring system[J]. Dev Period Med, 2019, 23(1): 7-14. pmid: 30954975
[26]	Jagła M, Szymońska I, Starzec K, et al. Defining glycemic variability in very low-birthweight infants: data from a continuous glucose monitoring system[J]. Diabetes Technol Ther, 2018, 20(11): 725-730. doi: 10.1089/dia.2018.0168
[27]	陈翠瑶. 新生儿危重病例评分与新生儿急性生理学评分围产期补充Ⅱ预测危重新生儿死亡风险的比较[D]. 广州: 南方医科大学, 2017.
[28]	Galderisi A, Facchinetti A, Steil GM, et al. Continuous glucose monitoring in very preterm infants: a randomized controlled trial[J]. Pediatrics, 2017, 140(4): e20171162.
[29]	Beardsall K, Thomson L, Guy C, et al. Protocol of a randomised controlled trial of real-time continuous glucose monitoring in neonatal intensive care 'REACT'[J]. BMJ Open, 2018, 8(6): e020816.
[30]	Dixon KC, Ferris RL, Marikar D, et al. Definition and monitoring of neonatal hypoglycaemia:a nationwide survey of NHS England Neonatal Units. Arch Dis Child Fetal Neonatal Ed. 2017 Jan;102(1): F92-F93.
[31].	Eskes PF, Nuytemans DHGM, et al. Lower versus traditional treatment threshold for neonatal hypoglycemia[J]. N Engl J Med, 2020, 382(6): 534-544. doi: 10.1056/NEJMoa1905593

项目	存活组(n=305)	死亡组(n=80)	统计量	P
男性[n(%)]	182(59.7)	46(57.5)	χ²=0.12	0.725
胎龄(x±s)/周	35.8±3.6	33.4±5.2	t=3.86	<0.001
体质量(x±s)/g	2555.2±796.8	2080.7±986.7	t=3.97	<0.001
CV[M(P₂₅~P₇₅)]	0.27(0.17~0.43)	0.41(0.31~0.64)	Z=5.94	<0.001
中位血糖[M(P₂₅~P₇₅)]/mmol·L^-1	4.68(4.17~5.30)	5.51(4.31~7.02)	Z=4.26	<0.001
初始血糖[M(P₂₅~P₇₅)]/mmol·L^-1	3.40(2.70~4.40)	3.60(2.38~6.05)	Z=1.95	0.052
低血糖[n(%)]	60(19.7)	25(31.2)	χ²=4.94	0.026
高血糖[n(%)]	62(20.3)	53(66.2)	χ²=63.80	<0.001
SNAPPE-Ⅱ[M(P₂₅~P₇₅)]	0.0(0.0~7.0)	29.5(8.5~44.0)	Z=10.46	<0.001
住院或死亡天数[M(P₂₅~P₇₅)]/d	9.0(6.0~15.0)	5.0(2.0~10.3)	Z=5.68	<0.001
机械通气天数[M(P₂₅~P₇₅)]/d	0.0(0.0~0.0)	2.0(0.0~5.0)	Z=13.81	<0.001
入院年龄[M(P₂₅~P₇₅)]/h	1.0(1.0~24.0)	3.0(1.0~14.0)	Z=3.40	0.001
妊娠期糖尿病[n(%)]	37(12.1)	7(8.8)	χ²=0.72	0.398
绒毛膜羊膜炎[n(%)]	14(4.6)	7(8.8)	χ²=1.40	0.237
主要诊断或死亡主要诊断
NRDS[n(%)]	153(50.2)	31(38.8)	χ²=3.31	0.069
新生儿窒息[n(%)]	59(19.3)	21(26.2)	χ²=1.84	0.175
新生儿败血症[n(%)]	42(13.8)	27(33.8)	χ²=17.20	<0.001
肺出血[n(%)]	3(1.0)	13(16.2)	χ²=33.35	<0.001
颅内出血[n(%)]	7(2.3)	3(3.8)	χ²=0.11	0.739
坏死性小肠结肠炎[n(%)]	8(2.6)	6(7.5)	χ²=3.02	0.082

变量	偏回归系数	标准误	χ²值	P	OR(95%CI)
截距	6.81	3.50	3.79	0.052	-
CV	2.00	1.00	4.01	0.045	7.36(1.04~51.96)
SNAPPE- II	0.09	0.01	46.23	<0.001	1.10(1.07~1.13)
胎龄	-0.25	0.11	5.18	0.023	0.78(0.63~0.97)
体质量	-0.00	0.00	3.89	0.049	1.00(1.00~1.00)
肺出血	2.90	0.97	8.96	0.003	18.09(2.72~120.47)
颅内出血	-0.43	1.08	0.16	0.689	0.65(0.08~5.36)
坏死性小肠结肠炎	0.95	0.69	1.89	0.169	2.57(0.67~9.90)
NRDS	-1.01	1.22	0.68	0.410	0.37(0.03~4.02)
新生儿窒息	1.97	1.09	3.29	0.070	7.17(0.85~60.25)
新生儿败血症	2.77	1.09	6.43	0.011	15.95(1.87~135.67)

变量	截断值	AUC(95%CI)	灵敏度	特异度	阳性预测值	阴性预测值
CV	0.31	0.72(0.66~0.78)	0.75	0.59	0.32	0.90
SNAPPE- II	18.50	0.85(0.79~0.90)	0.68	0.93	0.72	0.92

Association of coefficient of glycemic variation and SNAPPE-Ⅱ with prognosis in critically ill neonates

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 31.

Related Articles 15

Metrics

Comments

Recommended 0

[1]	XU Quan, YUAN Xiaojun. Diagnosis and treatment characteristics and long-term follow-up of 51 cases of infantile neuroblastoma [J]. Journal of Clinical Pediatrics, 2023, 41(9): 680-685.
[2]	WU Yuefang, SUN Yanling, WU Wanshui, DU Shuxu, LI Miao, SUN Liming. Analysis of prognostic factors and survival status of group 4 medulloblastoma in children [J]. Journal of Clinical Pediatrics, 2023, 41(9): 686-691.
[3]	SUN Juan, LI Haiying, JIA Peisheng, WANG Huaili. Clinical analysis of fulminant myocarditis in 12 children [J]. Journal of Clinical Pediatrics, 2023, 41(9): 692-696.
[4]	SUN Zhicai, LIU Yuling, LI Xiaolin, PAN Xiaofen. Clinical analysis of 15 children with primary nephrotic syndrome complicated with adrenal crisis [J]. Journal of Clinical Pediatrics, 2023, 41(8): 610-612.
[5]	QIAO Junying, ZHANG Luodan, LI Fan, ZHAO Jianchuang, GUO Shanshan, ZHANG Jingpo. The application value of 5 scoring methods in the prognosis evaluation of acute respiratory distress syndrome in children [J]. Journal of Clinical Pediatrics, 2023, 41(6): 442-449.
[6]	YANG Yang, CHI Xia, TONG Meiling, ZHOU Xiaoyu, CHENG Rui, PAN Jingjing, CHEN Xiaoqing. Predictive value of different neonatal illness severity scores for predischarge outcomes in very and extremely low birth weight infants [J]. Journal of Clinical Pediatrics, 2022, 40(8): 608-615.
[7]	ZHANG Zaiyu, LIANG Ping. Construction and validation of the prognosis nomogram of pediatric medulloblastoma based on clinical and tumor biological characteristics [J]. Journal of Clinical Pediatrics, 2022, 40(7): 527-533.
[8]	KANG Xiayan, ZHANG Xinping, FAN Jianghua, SONG Yulei, ZHOU Xiong, CAO Jianshe, HE Jie, XIAO Zhenghui. The relationship between serum insulin level and prognosis in children with sepsis associated encephalopathy [J]. Journal of Clinical Pediatrics, 2022, 40(3): 218-223.
[9]	LIU Yu, YUE Yingbin, YAN Mei. Correlation between serum ferritin level and prognosis of childhood acute lymphoblastic leukemia [J]. Journal of Clinical Pediatrics, 2022, 40(2): 113-117.
[10]	XU Min, ZHOU Wenjie, TANG Jihong, SHI Xiaoyan, ZHANG Bingbing, XIAO Xiao. Clinical analysis of 51 cases of acute lymphoblastic leukemia with seizures in children [J]. Journal of Clinical Pediatrics, 2022, 40(2): 118-122.
[11]	MAO Shuting, WANG Xin, LIU Yufeng. Clinical features and prognosis of 175 children with hemophagocytic lymphohistiocytosis [J]. Journal of Clinical Pediatrics, 2022, 40(2): 123-128.
[12]	LIU Zhichao, LI Changchun, WANG Shan, KONG Xiangru, ZHANG Jun, YANG Chao, ZHAO Zhenzhen. A retrospective clinical analysis of 21 cases of Castleman disease in children [J]. Journal of Clinical Pediatrics, 2022, 40(2): 139-143.
[13]	GAO Wenchao, SUN Yanling, LI Miao, REN Siqi, DU Shuxu, WU Wanshui, SUN Liming. Clinical features and prognostic factors of SHH medulloblastoma in children [J]. Journal of Clinical Pediatrics, 2022, 40(12): 919-924.
[14]	ZHANG Ting, LI Xiaowen. Analysis of risk factors for the prognosis of neonatal acute kidney injury [J]. Journal of Clinical Pediatrics, 2021, 39(9): 646-.
[15]	LI Hong, SHAO Jingbo, ZHU Jiashi, et al. Value of early treatment response to assess prognosis of children with acute lymphoblastic leukemia [J]. Journal of Clinical Pediatrics, 2021, 39(8): 600-.